Regonat 40 Mg (Regorafenib)
| Active Ingredient | Regorafenib |
|---|---|
| Indication: | Cancer of colon and rectum |
| Manufacturer: | Natco Pharma Ltd. |
| Packaging | 28 tablets in bottle |
| Strength | 40mg |
| Delivery Time | 6 To 15 days |
Regonat 40mg contains Regorafenib, an oral multikinase inhibitor used to treat various advanced cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer). It works by blocking multiple enzymes that promote tumor growth, angiogenesis (formation of new blood vessels), and cancer cell survival.
Regorafenib is typically prescribed when previous treatments have failed or stopped working. Regonat 40 mg tablets are taken orally, usually once daily for 21 days, followed by a 7-day break (28-day cycle), under the supervision of an oncologist.








There are no reviews yet.